AbbVie (GB:0QCV)
LSE:0QCV
Holding GB:0QCV?
Track your performance easily

AbbVie (0QCV) Technical Analysis

7 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
AbbVie’s (0QCV) Moving Averages Convergence Divergence (MACD) indicator is 1.77, suggesting AbbVie is a Buy.
AbbVie’s (0QCV) 20-Day exponential moving average is 193.95, while AbbVie’s (0QCV) share price is $193.079, making it a Sell.
AbbVie’s (0QCV) 50-Day exponential moving average is 187.79, while AbbVie’s (0QCV) share price is $193.079, making it a Buy.

AbbVie (0QCV) Pivot Points

Sep 18, 2024, 08:49 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
192.80
193.70
194.43
195.33
196.06
196.96
197.69
Fibonacci
193.70
194.32
194.70
195.33
195.95
196.33
196.96
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (0QCV) Moving Averages

Sep 18, 2024, 08:49 PM
Period
Simple
Exponential
MA5
194.18Sell
194.28Sell
MA10
194.78Sell
194.65Sell
MA20
195.46Sell
193.95Sell
MA50
187.00Buy
187.79Buy
MA100
175.01Buy
179.88Buy
MA200
169.65Buy
169.77Buy
AbbVie’s (0QCV) 10-Day exponential moving average is 194.65, while AbbVie’s (0QCV) share price is $193.079, making it a Sell.
AbbVie’s (0QCV) 100-Day exponential moving average is 179.88, while AbbVie’s (0QCV) share price is $193.079, making it a Buy.
AbbVie’s (0QCV) stock price is $193.079 and AbbVie’s (0QCV) 50-day simple moving average is 187.00, creating a Buy signal.
AbbVie’s (0QCV) stock price is $193.079 and AbbVie’s (0QCV) 100-day simple moving average is 175.01, creating a Buy signal.
AbbVie’s (0QCV) stock price is $193.079 and AbbVie’s (0QCV) 200-day simple moving average is 169.65, creating a Buy signal.

AbbVie (0QCV) Technical Indicators

Sep 18, 2024, 08:49 PM
Name
Value
Implied Action
RSI (14)
50.97
Neutral
STOCH (9,6)
32.21
Neutral
STOCHRSI (14)
31.28
Neutral
MACD (12,26)
1.77
Buy
ADX (14)
34.43
Neutral
Williams %R
-82.00
Buy
CCI (14)
-118.18
Buy
ATR (14)
3.39
-
Ultimate Oscillator
54.34
Neutral
ROC
-1.05
Sell
AbbVie’s (0QCV) Relative Strength Index (RSI) is 50.97, creating a Neutral signal.
AbbVie’s (0QCV) Trend Strength Indicator (ADX) is 34.43, creating a Neutral signal.
AbbVie’s (0QCV) Commodity Channel Index (CCI) is -118.18, creating a Buy signal.
AbbVie’s (0QCV) Price Rate of Change (ROC) is -1.05, creating a Sell signal.

FAQ

Is 0QCV a Buy, Hold, or Sell?
Based on 0QCV’s technical indicators, 0QCV is a Hold.
    What is 0QCV’s RSI (14)?
    0QCV’s RSI (14) is 50.97, which suggests 0QCV is a Neutral.
      What is 0QCV’s MACD?
      0QCV’s MACD is 1.77, which suggests 0QCV is a Buy.
        What is 0QCV’s 5-day moving average?
        0QCV’s 5-day moving average is 194.18, which suggests 0QCV is a Sell.
          What is 0QCV’s 20-day moving average?
          0QCV 20-day moving average is 195.46, which suggests 0QCV is a Sell.
            What is 0QCV’s 50-day moving average?
            0QCV’s 50-day moving average is 187.00, which suggests 0QCV is a Buy.
              What is 0QCV’s 200-day moving average?
              0QCV’s 200-day moving average is 169.65, which suggests 0QCV is a Buy.
                What is 0QCV’s Williams % R (14)?
                0QCV’s Williams % R (14) is -82.00, which suggests 0QCV is a Buy.
                  What is 0QCV’s CCI (14)?
                  0QCV’s CCI (14) is -118.18, which suggests 0QCV is a Buy.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis